Articles
14.02.2020
Drug price reductions in the US

Prescription drug prices in the US rank among the highest in the world and the US spent $1220 on ph...

Read more
Articles
13.02.2020
Westminster Health Forum

The Westminster Health Forum organise senior level conferences on public policy relating to health a...

Read more
Articles
30.01.2020
NICE EMA scientific advice

With the UKs withdrawal from the European Union, NICE’s relationship with EMA and indeed, the para...

Read more
Articles
06.12.2019
Further physician education

Maximising the cost-saving potential of biosimilars remains a topic of much interest to payers and p...

Read more
Articles
20.11.2019
When to get scientific advice

Discussing the benefits of seeking early scientific advice and what companies need to take into cons...

Read more
Articles
13.11.2019
Medical device market access

What are the pro’s and cons of seeking NICE approval using the Medical Technologies Evaluation Pro...

Read more
Publications
06.11.2019
Pricing and market access launch excellence

Pharmaceutical companies are incorporating payer / HTA needs into their clinical and commercial laun...

Read more
Articles
11.10.2019
EUnetHTAs joint assessment facilitating HTA

How to create, facilitate, and promote sustainable Health Technology Assessment (HTA) cooperation in...

Read more
Articles
03.10.2019
Pricing and market access launch excellence

This study aims to understand the industry perspective on drivers and challenges for a successful la...

Read more
Articles
26.09.2019
New reference pricing rules for Greece 2019

Medicine prices in Greece are set by the IRP. IRP is the process of using the prices in other countr...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.